InvestorsHub Logo

rosemountbomber

03/27/20 6:16 AM

#256781 RE: couldbebetter #256780

Could, what bothers me is that we have been told over the years waiting for a BO, wait for R-I results, wait for approval, wait for trial results, yada, yada. Meanwhile I see companies being bought out before even having reached phase III trials.

Whether it is JT with expectations that are too lofty or what I am not sure.

If we can believe what he says, there has been some interest in Europe but he admits he wants a higher valuation.

sharinky

03/27/20 6:59 AM

#256788 RE: couldbebetter #256780

Total scripts are where the revenue is at. That is all that matters.

Amarin may be the only company in 2020 that doesn't have to lower their guidance.